C. Ian Mockridge

3.1k total citations
43 papers, 2.1k citations indexed

About

C. Ian Mockridge is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, C. Ian Mockridge has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 28 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Genetics. Recurrent topics in C. Ian Mockridge's work include Monoclonal and Polyclonal Antibodies Research (28 papers), T-cell and B-cell Immunology (19 papers) and Chronic Lymphocytic Leukemia Research (14 papers). C. Ian Mockridge is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), T-cell and B-cell Immunology (19 papers) and Chronic Lymphocytic Leukemia Research (14 papers). C. Ian Mockridge collaborates with scholars based in United Kingdom, Netherlands and United States. C. Ian Mockridge's co-authors include Freda K. Stevenson, Kathleen N. Potter, Mark S. Cragg, Graham Packham, H.T. Claude Chan, Martin J. Glennie, Ruth R. French, Isla Wheatley, Stephen A. Beers and Ali Roghanian and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

C. Ian Mockridge

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ian Mockridge United Kingdom 28 1.3k 874 756 590 530 43 2.1k
Oliver Manzke Germany 19 676 0.5× 500 0.6× 405 0.5× 552 0.9× 549 1.0× 36 1.9k
Tom van Meerten Netherlands 17 692 0.5× 487 0.6× 414 0.5× 331 0.6× 602 1.1× 64 1.7k
Katerina Hatzi United States 24 1.1k 0.8× 208 0.2× 758 1.0× 1.1k 1.9× 711 1.3× 46 2.5k
Daming Shan United States 9 364 0.3× 507 0.6× 243 0.3× 292 0.5× 398 0.8× 9 974
J Erikson United States 7 525 0.4× 260 0.3× 369 0.5× 739 1.3× 519 1.0× 9 1.8k
Iman Jilani United States 21 492 0.4× 203 0.2× 814 1.1× 578 1.0× 557 1.1× 54 1.6k
L Bergui Italy 26 767 0.6× 222 0.3× 890 1.2× 735 1.2× 454 0.9× 53 2.3k
Sergey Krysov United Kingdom 15 472 0.4× 189 0.2× 671 0.9× 354 0.6× 535 1.0× 25 1.0k
KC Anderson United States 9 417 0.3× 263 0.3× 334 0.4× 258 0.4× 473 0.9× 12 1.2k
Carsten Zwick Germany 15 494 0.4× 184 0.2× 256 0.3× 424 0.7× 616 1.2× 32 1.3k

Countries citing papers authored by C. Ian Mockridge

Since Specialization
Citations

This map shows the geographic impact of C. Ian Mockridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ian Mockridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ian Mockridge more than expected).

Fields of papers citing papers by C. Ian Mockridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ian Mockridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ian Mockridge. The network helps show where C. Ian Mockridge may publish in the future.

Co-authorship network of co-authors of C. Ian Mockridge

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ian Mockridge. A scholar is included among the top collaborators of C. Ian Mockridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ian Mockridge. C. Ian Mockridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, H.T. Claude, Tatyana Inzhelevskaya, C. Ian Mockridge, et al.. (2025). Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonism. Nature Communications. 16(1). 3495–3495. 1 indexed citations
2.
Yu, Xiaojie, Christian M. Orr, H.T. Claude Chan, et al.. (2023). Reducing affinity as a strategy to boost immunomodulatory antibody agonism. Nature. 614(7948). 539–547. 71 indexed citations
3.
Allen, Joel D., Sarah L. Buchan, Jinny Kim, et al.. (2023). Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc. Frontiers in Immunology. 14. 1252274–1252274. 1 indexed citations
4.
Willoughby, Jane E., Martin C. Taylor, Steven G. Booth, et al.. (2022). Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments. Journal for ImmunoTherapy of Cancer. 10(1). e003735–e003735. 28 indexed citations
5.
Roghanian, Ali, Robert Oldham, H.T. Claude Chan, et al.. (2022). FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms. Cell Reports. 40(3). 111099–111099. 16 indexed citations
6.
Chan, H.T. Claude, Michael J. Marshall, Christine A. Penfold, et al.. (2022). Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering. Communications Biology. 5(1). 229–229. 12 indexed citations
7.
Yu, Xiaojie, Sonya James, James H. Felce, et al.. (2021). TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity. Communications Biology. 4(1). 772–772. 35 indexed citations
8.
Yu, Xiaojie, H.T. Claude Chan, Christine A. Penfold, et al.. (2020). Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity. Cancer Cell. 37(6). 850–866.e7. 48 indexed citations
9.
Oldham, Robert, C. Ian Mockridge, Sonya James, et al.. (2020). FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion. Journal for ImmunoTherapy of Cancer. 8(1). e000619–e000619. 12 indexed citations
10.
Cox, Kerry L., Christine A. Penfold, Ruth R. French, et al.. (2018). Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking. Scientific Reports. 8(1). 2278–2278. 30 indexed citations
11.
Tipton, Tom, C. Ian Mockridge, Ruth R. French, et al.. (2015). Anti-mouse Fc?RIV antibody 9E9 also blocks Fc?RIII in vivo. Blood. 1 indexed citations
12.
White, Ann L., H.T. Claude Chan, Ruth R. French, et al.. (2014). Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies. Cancer Cell. 27(1). 138–148. 125 indexed citations
13.
White, Ann L., H.T. Claude Chan, Ali Roghanian, et al.. (2011). Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody. The Journal of Immunology. 187(4). 1754–1763. 180 indexed citations
14.
Mockridge, C. Ian, et al.. (2007). Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 109(10). 4424–4431. 174 indexed citations
15.
McWhirter, John R., Anke Kretz-Rommel, Alan Saven, et al.. (2006). Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proceedings of the National Academy of Sciences. 103(4). 1041–1046. 130 indexed citations
16.
Mockridge, C. Ian, Anisur Rahman, Sarah L. Buchan, et al.. (2003). Common Patterns of B Cell Perturbation and Expanded V4-34 Immunoglobulin Gene Usage in Autoimmunity and Infection. Autoimmunity. 37(1). 9–15. 30 indexed citations
17.
Mockridge, C. Ian, Caroline Chapman, Myfanwy B. Spellerberg, David Isenberg, & Freda K. Stevenson. (1996). Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope. The Journal of Immunology. 157(6). 2449–2454. 27 indexed citations
18.
Chapman, Caroline, C. Ian Mockridge, Myfanwy B. Spellerberg, et al.. (1995). Use of a Phage Expression System to Produce Fabs from Human Autoanti‐DNA Antibodies Encoded by the VH4–21 Gene Segment. Annals of the New York Academy of Sciences. 764(1). 576–579.
19.
Wang, D.Y., H. Hamed, C. Ian Mockridge, & Ian S. Fentiman. (1989). Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid. European Journal of Cancer and Clinical Oncology. 25(5). 867–872. 17 indexed citations
20.
Fantl, Vera, Dennis Y. Wang, & C. Ian Mockridge. (1988). Measurement of human corticosteroid binding globulin by enzyme-linked immunoassay. Journal of Steroid Biochemistry. 31(2). 187–193. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026